Daksha Shah

668 total citations
24 papers, 310 citations indexed

About

Daksha Shah is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Daksha Shah has authored 24 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 13 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Daksha Shah's work include Tuberculosis Research and Epidemiology (15 papers), Pneumonia and Respiratory Infections (10 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Daksha Shah is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), Pneumonia and Respiratory Infections (10 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Daksha Shah collaborates with scholars based in India, United States and South Africa. Daksha Shah's co-authors include Ibrahim Khan, Dawood Shah, Jayanthi Shastri, Sandeep Juneja, Gagandeep Kang, Rajesh Jain, Ullas Kolthur‐Seetharam, Anup Malani, Manoj Mohanan and Sachee Agrawal and has published in prestigious journals such as PLoS ONE, BMJ Open and Journal of Thoracic Oncology.

In The Last Decade

Daksha Shah

18 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daksha Shah India 8 144 74 67 62 56 24 310
Harshwardhan Khandait United States 6 137 1.0× 67 0.9× 31 0.5× 34 0.5× 63 1.1× 22 305
Lara Goscé United Kingdom 7 63 0.4× 113 1.5× 18 0.3× 47 0.8× 50 0.9× 23 247
Rebecca A. Stern United States 7 45 0.3× 57 0.8× 33 0.5× 41 0.7× 61 1.1× 10 342
Asami Anzai Japan 6 59 0.4× 161 2.2× 26 0.4× 92 1.5× 32 0.6× 12 244
Garyfallos Konstantinoudis United Kingdom 12 86 0.6× 151 2.0× 67 1.0× 56 0.9× 73 1.3× 22 542
Víctor Herrera Colombia 14 79 0.5× 31 0.4× 23 0.3× 27 0.4× 50 0.9× 37 477
Esra Ozdenerol United States 12 57 0.4× 25 0.3× 31 0.5× 47 0.8× 28 0.5× 27 311
Anna Nguyen United States 7 170 1.2× 131 1.8× 9 0.1× 33 0.5× 82 1.5× 20 356
Andy Ross United States 5 121 0.8× 196 2.6× 23 0.3× 34 0.5× 50 0.9× 6 547
Lipeng Hao China 13 82 0.6× 78 1.1× 18 0.3× 29 0.5× 168 3.0× 30 468

Countries citing papers authored by Daksha Shah

Since Specialization
Citations

This map shows the geographic impact of Daksha Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daksha Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daksha Shah more than expected).

Fields of papers citing papers by Daksha Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daksha Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daksha Shah. The network helps show where Daksha Shah may publish in the future.

Co-authorship network of co-authors of Daksha Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Daksha Shah. A scholar is included among the top collaborators of Daksha Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daksha Shah. Daksha Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Limaye, Sewanti, R. Vijayakumar, Nirav N. Shah, et al.. (2025). 403P: Higher predilection of driver mutation positive squamous lung cancer in the Asia Pacific region. Journal of Thoracic Oncology. 20(3). S234–S234.
3.
4.
Khan, Sumaiya, et al.. (2024). Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 37. 100481–100481. 1 indexed citations
5.
Shenai, Shubhada, et al.. (2023). Simultaneous screening for COVID-19 and tuberculosis, India. Bulletin of the World Health Organization. 101(7). 445–452.
6.
Shah, Daksha, et al.. (2022). COVID-19 Serological Survey-3 Prior to Second Wave in Mumbai, India. Indian Journal of Community Medicine. 47(1). 61–65.
7.
Nilgiriwala, Kayzad, Ambreen Shaikh, Aruna Poojary, et al.. (2022). Genomics of postvaccination SARS‐CoV‐2 infections during the Delta dominated second wave of COVID‐19 pandemic, from Mumbai Metropolitan Region (MMR), India. Journal of Medical Virology. 94(9). 4206–4215. 7 indexed citations
8.
Sriraman, Kalpana, et al.. (2022). Impact of COVID‐19 vaccination on transmission risk of breakthrough infections: Lessons from adapted N95 mask sampling for emerging variants and interventions. Journal of Medical Virology. 95(1). e28188–e28188. 2 indexed citations
9.
Mistry, Nerges, Elena C. Hemler, Yatin Dholakia, et al.. (2020). Protocol for a case–control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India. BMJ Open. 10(11). e039935–e039935. 4 indexed citations
10.
Khan, Ibrahim, Daksha Shah, & Dawood Shah. (2020). COVID-19 pandemic and its positive impacts on environment: an updated review. International Journal of Environmental Science and Technology. 18(2). 521–530. 126 indexed citations
11.
Malani, Anup, Daksha Shah, Gagandeep Kang, et al.. (2020). Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India. The Lancet Global Health. 9(2). e110–e111. 78 indexed citations
12.
Shah, Daksha, et al.. (2019). Should vitamin D be routinely checked for all chronic obstructive pulmonary disease patients?. Lung India. 36(6). 492–492. 5 indexed citations
13.
Deo, Sarang, Devesh Gupta, Sunil Khaparde, et al.. (2019). What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India. PLoS ONE. 14(6). e0214928–e0214928. 15 indexed citations
14.
Shah, Daksha, et al.. (2019). Map, know dynamics and act; a better way to engage private health sector in TB management. A report from Mumbai, India. Indian Journal of Tuberculosis. 67(1). 65–72. 6 indexed citations
15.
Mehta, Preeti, et al.. (2018). Pattern of missing probes in rifampicin resistant TB by Xpert MTB/RIF assay at a tertiary care centre in Mumbai. Indian Journal of Tuberculosis. 66(1). 139–143. 9 indexed citations
16.
Shah, Daksha, Kanchan Ajbani, Mubin Kazi, et al.. (2018). Evaluation of pyrosequencing for extensive drug resistance-defining anti-tuberculosis drugs for use in public healthcare. Tuberculosis. 110. 86–90. 4 indexed citations
17.
Shah, Daksha, et al.. (2018). Performance of Xpert MTB/RIF for detection of Mycobacterium tuberculosis and rifampicin resistance in pus aspirates. Indian Journal of Tuberculosis. 66(4). 433–436. 4 indexed citations
18.
Shah, Daksha, et al.. (2018). Diagnostic Accuracy of Xpert MTB/RIF Assay in Extrapulmonary Tuberculosis. Indian Journal of Medical Microbiology. 36(3). 357–363. 14 indexed citations
19.
Shah, Daksha, et al.. (2016). Empowering the community to manage diabetes better: An integrated partnership-based model. Indian Journal of Community Medicine. 41(2). 162–162. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harshwardhan Khandait Breakdown of academic impact, for papers by Lara Goscé Breakdown of academic impact, for papers by Rebecca A. Stern Breakdown of academic impact, for papers by Asami Anzai Breakdown of academic impact, for papers by Garyfallos Konstantinoudis Breakdown of academic impact, for papers by Víctor Herrera Breakdown of academic impact, for papers by Esra Ozdenerol Breakdown of academic impact, for papers by Anna Nguyen Breakdown of academic impact, for papers by Andy Ross Breakdown of academic impact, for papers by Lipeng Hao
Rankless by CCL
2026